Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
about
A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release.Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.In vitro synergistic action of geldanamycin- and docetaxel-containing HPMA copolymer-RGDfK conjugates against ovarian cancerAnticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrugPolymeric conjugates for drug deliveryCellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation sitePolymer-drug conjugates for novel molecular targets.Tumor Targeting via Integrin Ligands.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Star-shaped tetraspermine enhances cellular uptake and cytotoxicity of T-oligo in prostate cancer cells.The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment.Delivery of HSP90 Inhibitor Using Water Soluble Polymeric Conjugates with High Drug Payload.Polymer conjugates for focal and targeted delivery of drugsLigand-Assisted Vascular Targeting of Polymer Therapeutics
P2860
Q30860444-3D7AD659-B12E-48B1-A54B-2874A42C6651Q33836864-3872B840-EC4D-4F60-833B-376E3B6F2EC3Q34674722-C5E4DC21-46F7-4135-8937-7EC9859EEC26Q34984769-6684DCA1-6FB0-490E-AD65-80959845FA16Q35227265-828EE866-9229-44C2-A758-DD6051E19829Q35981228-C6770823-F876-44B9-AEC8-D31E345C3ECCQ36029175-A51619A5-962A-4786-8591-72F49E1EE3BDQ36837220-0C0FC8B6-1C4C-4BB6-9A48-93C897D8F92DQ37782076-144491AE-65BD-4A1E-814C-4C390D1A5265Q38134759-59E27B0C-D529-4D2E-9344-16BA443D9B02Q38161395-E4568CEA-666B-46FF-B696-445A28CA622BQ38305253-1AB79384-4A15-4FD6-8B11-7F532620D3E4Q38941448-8708586C-517E-47CC-83CA-417D58401C0EQ39443391-C0470D66-8031-4BA3-A6D5-86B1629942BAQ47797544-CA17A1C4-7398-4A4A-B180-67E09BA38705Q57617343-40BE30A6-B6A8-4BDA-83B1-BF24033C8C97Q57617349-09AC3C28-F205-4877-8F44-DAFF07255C15
P2860
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@en
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@nl
type
label
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@en
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@nl
prefLabel
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@en
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@nl
P2093
P2860
P1476
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
@en
P2093
Abhijit Ray
Angelika M Burger
Edward A Sausville
Hamidreza Ghandehari
Mark P Borgman
Rohit B Kolhatkar
P2860
P304
P356
10.1007/S11095-009-9851-0
P577
2009-02-19T00:00:00Z